Epic Research Update : Strides Arcolab

Strides Arcolab has received US Food and Drug Administration (US FDA) approval for Adenoscan Injection Generic. Astellas Pharma’s heart drug Adenoscan sales stood at $65 million per year. Teva pharma’s Adenoscan exclusivity has ended on March 23, 2014.

For more information ✆ - 0731-6642300 or Visit http://ift.tt/1doLhaI

Posted in: Indian Market Tips